Similar articles

• COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study.

  Miravitlles M, Izquierdo I, Herrejón A, Torres JV, Baró E, Borja J; ESFERA investigators. Miravitlles M, et al. Respir Med. 2011 May;105(5):740-7. doi: 10.1016/j.rmed.2010.12.020. Epub 2011 Jan 12. Respir Med. 2011. PMID: 21227672
• A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.

  File TM Jr, Monte SV, Schentag JJ, Paladino JA, Klugman KP, Lavin B, Yu VL, Singer ME, Adelman MH. File TM Jr, et al. Int J Antimicrob Agents. 2009 Jan;33(1):58-64. doi: 10.1016/j.ijantimicag.2008.07.019. Epub 2008 Oct 1. Int J Antimicrob Agents. 2009. PMID: 18835762
• Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations.

  Mallia P, Johnston SL. Mallia P, et al. Proc Am Thorac Soc. 2005;2(4):361-6; discussion 371-2. doi: 10.1513/pats.200504-025SR. Proc Am Thorac Soc. 2005. PMID: 16267363 Review.
• Natural history of successive COPD exacerbations.

  Wedzicha JA, Donaldson GC. Wedzicha JA, et al. Thorax. 2012 Nov;67(11):935-6. doi: 10.1136/thoraxjnl-2012-202087. Epub 2012 Aug 2. Thorax. 2012. PMID: 22858927 No abstract available.
• The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.

  Niewoehner DE. Niewoehner DE. Am J Med. 2006 Oct;119(10 Suppl 1):38-45. doi: 10.1016/j.amjmed.2006.08.006. Am J Med. 2006. PMID: 16996898 Review.